WBR0249: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}, {{AJL}} {{Alison}}
|QuestionAuthor={{Rim}} (Reviewed by {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Genetics
|MainCategory=Genetics
Line 8: Line 8:
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|MainCategory=Genetics
|MainCategory=Genetics
|MainCategory=Genetics
|MainCategory=Genetics
|MainCategory=Genetics
Line 20: Line 21:
|MainCategory=Genetics
|MainCategory=Genetics
|SubCategory=Neurology
|SubCategory=Neurology
|Prompt=A mother brings her 2-year-old male child to the physician's office, after noticing that, over the past few months, he has been developing abnormally. The mother reports that the child is frequently irritable, cries more than usual, and his growth has slowed. Upon physical exam, you notice that the infant's weight falls lower than the 3rd percentile on the standard growth chart and is experiencing abdominal distention. Urine testing displays elevated levels of vanillymandelic acid (VMA) and homovanillic acid (HVA). You suspect the presence of an extracranial neurological malignancy, which frequently occurs in the adrenal glands.  Mutation in which of the following genes is most likely associated with the patient's condition?
|Prompt=A 2-year-old boy is brought to the physician's office for an abdominal mass. The mother also reports that the child is frequently irritable, cries more than usual, and has a slowed growth. The infant's weight falls lower than the 3rd percentile on the standard growth chart. Physical examination is remarkable for opsoclonus-myoclonus, abdominal distention, and a palpable left abdominal mass. Urine testing demonstrates elevated levels of vanillylmandelic acid (VMA) and homovanillic acid (HVA). Amplification of which gene is associated with worse clinical outcomes in this patient's condition?
 
|Explanation=Neuroblastoma is a neural crest cell-derived embryonal tumor of the autonomic nervous system. It commonly affects children of 1 or 2 years of age. Neuroblastoma commonly manifests as an adrenal tumor or a tumor of the paraspinal ganglia in the neck, chest, abdomen, or pelvis. The clinical disease may range from a completely asymptomatic course with an incidental palpation of a unilateral/bilateral abdominal mass to severe illness, including neurological manifestations (Horner syndrome, blindness, opsoclonus, which is multivectorial, conjugate fast eye movements, and myoclonus, which is involuntary muscle twitching). The tumor results in defective synthesis of catecholamines and leads to the accumulation of catecholamine-metabolites, such as homovanillic acid (HVA) and vanillylmandelic acid (VMA). Elevations in these metabolites are observed in more than 90% of neuroblastoma cases and provide an important diagnostic clue.
|Explanation= The patient's symptoms of failure to thrive, irritability, and abdominal distention in conjunction with the elevated levels of urine VMA and HVA in the urine, points towards the diagnosis of [[neuroblastoma]], associated with a mutation in the [[N-myc]] oncogene.
 
|EducationalObjectives= The patient's symptoms of failure to thrive, irritability, and abdominal distention in conjunction with the elevated levels of urine VMA and HVA in the urine, points towards the diagnosis of [[neuroblastoma]], associated with a mutation in the [[N-myc]] oncogene.  
|References= First Aid 2014 page 318


|AnswerA=N-myc
The development of familial neuroblastoma has recently been attributed to either activating mutations in anaplastic lymphoma kinase (''ALK'') oncogene or loss-of-function mutations in homeobox gene ''PHOX2B''. Familial neuroblastoma has also been associated with other disorders, such as congenital hypoventilation syndrome and Hirschsprung's disease. In contrast, sporadic development of neuroblastoma has been attributed to multiple polymorphic gene interactions with no unique causative mutation. The presence of the ''N-MYC'' oncogene, a target of the high-level amplification at chromosome 2, is present in 20% of neuroblastoma cases. Identification of ''N-MYC'' amplification in neuroblastoma is clinically important because it is associated with worse clinical outcomes and may affect the management strategy through intensification of chemoradiation.
|AnswerAExp= The [[N-myc]] oncogene is associated with [[Neuroblastoma]].
|AnswerA=''N-MYC''
|AnswerB=Ret
|AnswerAExp='Presence of '[[N-MYC]]'' oncogene amplification is associated with worse clinical outcomes in neuroblastoma.
|AnswerBExp= The [[Ret gene|Ret oncogene]] is associated with [[MEN|MEN syndrome]], type IIa and IIb.
|AnswerB=RET
|AnswerC=Abl
|AnswerBExp=''[[RET]]'' is associated with multiple endocrine neoplasia (MEN) types 2A and 2B
|AnswerCExp= The [[Abl gene|Abl oncogene]] is associated with CML.
|AnswerCExp=The [[Abl gene|Abl oncogene]] is associated with CML.
|AnswerD=L-myc
|AnswerD=L-MYC
|AnswerDExp= The [[L-myc]] oncogene is associated with [[lung cancer]].
|AnswerDExp=''[[L-MYC]]'' oncogene is associated with [[lung cancer]].
|AnswerE=C-myc
|AnswerE=''[[C-MYC]]''
|AnswerEExp= The [[C-myc]] is associated with [[Burkitt's lymphoma]].
|AnswerEExp=''[[C-MYC]]'' oncogene is associated with [[Burkitt's lymphoma]].
|EducationalObjectives=Neuroblastoma is a neural crest cell-derived embryonal tumor of the autonomic nervous system. Identification of ''N-MYC'' amplification in neuroblastoma is clinically important because ''N-MYC'' amplification is associated with worse clinical outcomes.
|References=Maris JM. Recent advances in Neuroblastoma. N Engl J Med. 2010;362:2202-11.<br>
First Aid 2014 page 318
|RightAnswer=A
|RightAnswer=A
|WBRKeyword=Neuroblastoma, Opsoclonus, Myoclonus, N-MYC, Oncogene, Prognosis, Abdominal mass
|Approved=Yes
|Approved=Yes
}}
}}

Revision as of 02:04, 9 November 2014

 
Author [[PageAuthor::Rim Halaby, M.D. [1] (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics
Sub Category SubCategory::Neurology
Prompt [[Prompt::A 2-year-old boy is brought to the physician's office for an abdominal mass. The mother also reports that the child is frequently irritable, cries more than usual, and has a slowed growth. The infant's weight falls lower than the 3rd percentile on the standard growth chart. Physical examination is remarkable for opsoclonus-myoclonus, abdominal distention, and a palpable left abdominal mass. Urine testing demonstrates elevated levels of vanillylmandelic acid (VMA) and homovanillic acid (HVA). Amplification of which gene is associated with worse clinical outcomes in this patient's condition?]]
Answer A AnswerA::''N-MYC''
Answer A Explanation [[AnswerAExp::'Presence of 'N-MYC oncogene amplification is associated with worse clinical outcomes in neuroblastoma.]]
Answer B AnswerB::RET
Answer B Explanation [[AnswerBExp::RET is associated with multiple endocrine neoplasia (MEN) types 2A and 2B]]
Answer C AnswerC::
Answer C Explanation [[AnswerCExp::The Abl oncogene is associated with CML.]]
Answer D AnswerD::L-MYC
Answer D Explanation [[AnswerDExp::L-MYC oncogene is associated with lung cancer.]]
Answer E [[AnswerE::C-MYC]]
Answer E Explanation [[AnswerEExp::C-MYC oncogene is associated with Burkitt's lymphoma.]]
Right Answer RightAnswer::A
Explanation [[Explanation::Neuroblastoma is a neural crest cell-derived embryonal tumor of the autonomic nervous system. It commonly affects children of 1 or 2 years of age. Neuroblastoma commonly manifests as an adrenal tumor or a tumor of the paraspinal ganglia in the neck, chest, abdomen, or pelvis. The clinical disease may range from a completely asymptomatic course with an incidental palpation of a unilateral/bilateral abdominal mass to severe illness, including neurological manifestations (Horner syndrome, blindness, opsoclonus, which is multivectorial, conjugate fast eye movements, and myoclonus, which is involuntary muscle twitching). The tumor results in defective synthesis of catecholamines and leads to the accumulation of catecholamine-metabolites, such as homovanillic acid (HVA) and vanillylmandelic acid (VMA). Elevations in these metabolites are observed in more than 90% of neuroblastoma cases and provide an important diagnostic clue.

The development of familial neuroblastoma has recently been attributed to either activating mutations in anaplastic lymphoma kinase (ALK) oncogene or loss-of-function mutations in homeobox gene PHOX2B. Familial neuroblastoma has also been associated with other disorders, such as congenital hypoventilation syndrome and Hirschsprung's disease. In contrast, sporadic development of neuroblastoma has been attributed to multiple polymorphic gene interactions with no unique causative mutation. The presence of the N-MYC oncogene, a target of the high-level amplification at chromosome 2, is present in 20% of neuroblastoma cases. Identification of N-MYC amplification in neuroblastoma is clinically important because it is associated with worse clinical outcomes and may affect the management strategy through intensification of chemoradiation.
Educational Objective: Neuroblastoma is a neural crest cell-derived embryonal tumor of the autonomic nervous system. Identification of N-MYC amplification in neuroblastoma is clinically important because N-MYC amplification is associated with worse clinical outcomes.
References: Maris JM. Recent advances in Neuroblastoma. N Engl J Med. 2010;362:2202-11.
First Aid 2014 page 318]]

Approved Approved::Yes
Keyword WBRKeyword::Neuroblastoma, WBRKeyword::Opsoclonus, WBRKeyword::Myoclonus, WBRKeyword::N-MYC, WBRKeyword::Oncogene, WBRKeyword::Prognosis, WBRKeyword::Abdominal mass
Linked Question Linked::
Order in Linked Questions LinkedOrder::